New skin templates to prevent and treat infections in wounds
Official title: Novel dermal templates for prevention and treatment of biofilms in cutaneous wounds
Funded at Gel4med, INC. · NIH-11194640 · Data updated 2026-11-12
This study is testing a new skin template that helps heal wounds and keeps them safe from infections, especially for people with diabetic foot ulcers and other similar wounds.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gel4med, INC. NIH-funded |
| Lab location | 1 site (Brighton, United States) |
| Project start | April 1, 2019 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $1,050,000 |
| NIH project number | 2R44AI143079-02 |
| Project ID | NIH-11194640 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with diabetic foot ulcers or other chronic wounds that are at risk of infection.
✕Less likely to help
Patients with wounds that are not prone to infection or those who do not have chronic wound conditions may not benefit from this research.
What this research studies
This research focuses on developing a new type of skin template designed to prevent and eliminate harmful biofilms in both acute and chronic wounds. The approach involves creating a peptide-based tissue scaffolding matrix called G4B, which closely conforms to the wound bed, ensuring full coverage and minimizing spaces where bacteria can thrive. By utilizing this innovative membrane, the research aims to enhance wound healing and reduce the risk of infections that can complicate recovery. Patients with diabetic foot ulcers and other wounds that are prone to infection may particularly benefit from this treatment.
Why it matters
Potential benefit: If successful, this research could significantly improve wound healing and reduce the incidence of infections in patients with chronic and acute wounds.
How similar studies have gone: Previous research has shown promise in using peptide-based materials for wound healing, indicating that this approach may lead to successful outcomes.
Where this research is happening
-
Gel4med, INC.
Brighton, United States Active
Researchers
- Principal investigator: Mehta, Manav — Gel4med, INC.
- Study coordinator: Mehta, Manav
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.